Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis

被引:388
作者
Martin, R
Paty, P
Fong, YM
Grace, A
Cohen, A
DeMatteo, R
Jarnagin, W
Blumgart, L
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[2] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA
关键词
D O I
10.1016/S1072-7515(03)00390-9
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: The optimal surgical strategy for the treatment of synchronous resectable colorectal liver metastasis has not been defined. The aims of this study were to review our experience with synchronous colorectal metastasis and to define the safety of simultaneous versus staged resection of the colon and liver. STUDY DESIGN: From September 1984 through November 2001, 240 patients were treated surgically for primary adenocarcinoma of the large bowel and synchronous hepatic metastasis. Clinicopathologic, operative, and perioperative data were reviewed to evaluate selection criteria, operative methods, and perioperative outcomes. RESULTS: One hundred thirty-four patients underwent simultaneous resection of a colorectal primary and hepatic metastasis in a single operation (Group 1), and 106 patients underwent staged operations (Group 11). Simultaneous resections tend to be performed for right colon primaries (p < 0.001), smaller (p < 0.01) and fewer (p < 0.001) liver metastases, and less extensive liver resection (p < 0.001). Complications were less common in the simultaneous resection group, with 65 patients (49%) sustaining 142 complications, compared with 71 patients (67%) sustaining 197 complications for both hospitalizations in the staged resection group (p < 0.003). Patients having simultaneous resection required fewer days in the hospital (median 10 days versus 18 days, p = 0.001). Perioperative mortality was similar (simultaneous, n = 3; staged, n = 3). CONCLUSIONS: Simultaneous colon and liver resection is safe and efficient in the treatment of patients with colorectal cancer and synchronous liver metastasis. By avoiding a second laparotomy, the overall complication rate is reduced, with no change in operative mortality. Given its reduced morbidity, shorter treatment time, and similar cancer outcomes, simultaneous resection should be considered a safe option in patients with resectable synchronous colorectal metastasis. (C) 2003 by the American College of Surgeons.
引用
收藏
页码:233 / 241
页数:9
相关论文
共 29 条
  • [1] BELGHITI J, 1990, ANN CHIR, V44, P427
  • [2] SURGERY FOR SYNCHRONOUS HEPATIC METASTASES OF COLORECTAL-CANCER
    BISMUTH, H
    CASTAING, D
    TRAYNOR, O
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1988, 23 : 144 - 149
  • [3] RESECTION AND EMBOLIZATION IN THE MANAGEMENT OF SECONDARY HEPATIC-TUMORS
    BLUMGART, LH
    ALLISON, DJ
    [J]. WORLD JOURNAL OF SURGERY, 1982, 6 (01) : 32 - 45
  • [4] Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma
    Bolton, JS
    Fuhrman, GM
    [J]. ANNALS OF SURGERY, 2000, 231 (05) : 743 - 750
  • [5] CADY B, 1970, SURG GYNECOL OBSTETR, V131, P697
  • [6] Couinaud C., 1957, FOIE ETUDES ANATOMIQ
  • [7] Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases
    DeMatteo, RP
    Palese, C
    Jarnagin, WR
    Sun, RL
    Blumgart, LH
    Fong, Y
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2000, 4 (02) : 178 - 184
  • [8] IS SIMULTANEOUS HEPATECTOMY AND INTESTINAL ANASTOMOSIS SAFE
    ELIAS, D
    DETROZ, B
    LASSER, P
    PLAUD, B
    JERBI, G
    [J]. AMERICAN JOURNAL OF SURGERY, 1995, 169 (02) : 254 - 260
  • [9] Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer - Analysis of 1001 consecutive cases
    Fong, Y
    Fortner, J
    Sun, RL
    Brennan, MF
    Blumgart, LH
    [J]. ANNALS OF SURGERY, 1999, 230 (03) : 309 - 318
  • [10] Liver resection for colorectal metastases
    Fong, YM
    Cohen, AM
    Fortner, JG
    Enker, WE
    Turnbull, AD
    Coit, DG
    Marrero, AM
    Prasad, M
    Blumgart, LH
    Brennan, MF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 938 - 946